Philogene, Inc.
1Patents
1Active
1Granted
40Portfolio score
Filing activity: Oct 26, 2008 → Oct 26, 2008 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8592563B2 | Antibodies specific to pro-angiogenic isoforms of vascular endothelial growth factor (VEGF) | Chemistry; Metallurgy | 8 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.